PT  - JOURNAL ARTICLE
AU  - Mahajan, Ashutosh
AU  - Solanki, Ravi
AU  - Sivadas, Namitha
TI  - An Epidemic Model SIPHERD and its application for prediction of the spread of COVID-19 infection in India
AID  - 10.1101/2020.06.25.20139782
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.25.20139782
4099  - http://medrxiv.org/content/early/2020/06/26/2020.06.25.20139782.short
4100  - http://medrxiv.org/content/early/2020/06/26/2020.06.25.20139782.full
AB  - After originating from Wuhan, China, in late 2019, with a gradual spread in the last few months, COVID-19 has become a pandemic crossing 9 million confirmed positive cases and 450 thousand deaths. India is not only an overpopulated country but has a high population density as well, and at present, a high-risk nation where COVID-19 infection can go out of control. In this paper, we employ a compartmental epidemic model SIPHERD for COVID-19 and predict the total number of confirmed, active and death cases, and daily new cases. We analyze the impact of lockdown and the number of tests conducted per day on the prediction and bring out the scenarios in which the infection can be controlled faster. Our findings indicate that increasing the tests per day at a rapid pace (10k per day increase), stringent measures on social-distancing for the coming months and strict lockdown in the month of July all have a significant impact on the disease spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is not supported by any funding agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work does not need any approval of the IRB/oversight body.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe number of total positive or confirmed cases, present active cases, and deaths are collected from publicly available data [1], [2], and the number of tests per day from [3]. [1] https://www.worldometers.info/coronavirus. [2] https://www.covid19india.org. [3] https://ourworldindata.org/grapher/full-list-covid-19-tests-per-day. https://www.worldometers.info/coronavirus https://www.covid19india.org https://ourworldindata.org/grapher/full-list-covid-19-tests-per-day